Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Orexigen Therapeutics Inc (NASDAQ:OREX)

3.46
Delayed Data
As of Sep 23
 +0.01 / +0.29%
Today’s Change
3.18
Today|||52-Week Range
34.40
-79.88%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
AssetsCash78.3M98.1M104.2M155.4M
 
 
 
 
 
Short Term Investment Cash-23.4M19.8M6.1M51.1M
 
 
 
 
 
Cash & Short Term Investments137.4M177.0M205.5M214.0M
 
 
 
 
 
 
ReceivablesReceivables--0.002.6M6.8M
 
 
 
 
InventoriesInventories--0.001.2M10.8M
 
 
 
 
Current AssetsOther Current Assets1.5M1.3M2.0M2.3M
 
 
 
 
 
Current Assets138.9M178.3M211.3M233.9M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross2.0M2.6M2.9M3.5M
 
 
 
 
 
Depreciation-1.9M-1.9M-2.1M-2.2M
 
 
 
 
 
Other Assets0.001.0M621.0K1.3M
 
 
 
 
Total Assets139.2M180.1M213.0M236.6M
 
 
 
 
 
 
LiabilitiesAccounts Payable3.8M4.8M4.2M6.5M
 
 
 
 
 
Accrued Expenses13.9M9.9M12.6M10.7M
 
 
 
 
 
Other Current Liabilities17.3M13.3M20.8M20.3M
 
 
 
 
 
Other Liabilities25.1M22.9M29.7M32.2M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt0.0080.0M83.9M88.1M
 
 
 
 
Deferred Taxes0.000.00-547.0K0.00
 
 
Other Liabilities0.00232.0K354.0K150.0K
 
 
 
 
Total Liabilities63.7M138.3M190.6M203.2M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity75.5M41.9M22.3M33.4M
 
 
 
 
 
Total Shareholder Equity75.5M41.9M22.3M33.4M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding8.4M10.5M12.3M14.6M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.